What I like is the man himself is on floor and ensures compliance as FDA standards are super stringent and training staff of not being casual is important.
And culture of quality will lead to path of sucess.
I am a shareholder since 2017 and believe the best times for the business of run in same letter and spirit shall come by 2026.
Having said that following are my concerns:-
1.Less of negligible institutional interest
- Abrupt exit of a marquee investor in the past.
What is that we are missing if all the things are good ?
One should always have antithesis pointers
| Subscribe To Our Free Newsletter |
